Clinical biomarker innovation: when is it worthwhile?
Publication year
2019Source
Clinical Chemistry and Laboratory Medicine, 57, 11, (2019), pp. 1712-1720ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Health Evidence
Internal Medicine
SW OZ BSI KLP
Laboratory Medicine
Operating Rooms
Journal title
Clinical Chemistry and Laboratory Medicine
Volume
vol. 57
Issue
iss. 11
Page start
p. 1712
Page end
p. 1720
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 0: Other Research RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 13: Stress-related disorders DCMN: Donders Center for Medical Neuroscience; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227693]
- Electronic publications [107311]
- Faculty of Medical Sciences [86198]
- Faculty of Social Sciences [28418]
- Open Access publications [76433]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.